- Home
- DAWN vs KIDS Comparison
DAWN vs KIDS Comparison
Compare DAWN & KIDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAWN | KIDS |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 624.8M | 524.3M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | DAWN | KIDS |
|---|---|---|
| Price | $7.97 | $18.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $26.56 | $24.86 |
| AVG Volume (30 Days) | ★ 2.7M | 204.8K |
| Earning Date | 11-04-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $133,672,000.00 | ★ $227,410,000.00 |
| Revenue This Year | $15.51 | $16.58 |
| Revenue Next Year | $49.99 | $12.46 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 31.11 | 19.90 |
| 52 Week Low | $5.64 | $15.28 |
| 52 Week High | $13.92 | $27.60 |
Technical Indicators
Market Signals| Indicator | DAWN | KIDS |
|---|---|---|
| Relative Strength Index (RSI) | 42.36 | 58.65 |
| Support Level | $8.16 | $17.53 |
| Resistance Level | $8.60 | $19.30 |
| Average True Range (ATR) | 0.54 | 0.71 |
| MACD | -0.17 | 0.12 |
| Stochastic Oscillator | 2.16 | 73.96 |
Price Performance
Historical ComparisonAbout DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.